Irrespective of age, patients with aggressive Waldenstrom macroglobulinemia (WM) who have exhausted chemo-immunotherapy-based approaches may be candidates for allogeneic hematopoietic cell transplantation (HCT), a strategy that has been rarely attempted.[1][1]–[7][2]… Click to show full abstract
Irrespective of age, patients with aggressive Waldenstrom macroglobulinemia (WM) who have exhausted chemo-immunotherapy-based approaches may be candidates for allogeneic hematopoietic cell transplantation (HCT), a strategy that has been rarely attempted.[1][1]–[7][2] In Seattle, conditioning with
               
Click one of the above tabs to view related content.